Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID P11166 6513 SLC2A1 GLUT1 Glut1 deficiency syndrome Glycosylation N N45 P11166 6513 SLC2A1 GLUT1 Hepatocellular carcinoma Glycosylation N N45 P11166 6513 SLC2A1 GLUT1 Stomach adenocarcinoma Glycosylation N N45 P11166 6513 SLC2A1 GLUT1 Glut1 deficiency syndrome N-linked glycosylation N N45 P11166 6513 SLC2A1 GLUT1 Hepatocellular carcinoma N-linked glycosylation N N45 P11166 6513 SLC2A1 GLUT1 Stomach adenocarcinoma N-linked glycosylation N N45 P11166 6513 SLC2A1 GLUT1 Colon adenocarcinoma Phosphorylation N S226 P11166 6513 SLC2A1 GLUT1 Epilepsy Phosphorylation N S226 P11166 6513 SLC2A1 GLUT1 Glut1 deficiency syndrome Phosphorylation N S226 P11166 6513 SLC2A1 GLUT1 Uterine corpus endometrial carcinoma Phosphorylation N S226 P11166 6513 SLC2A1 GLUT1 Colon adenocarcinoma Phosphorylation N T234 P11166 6513 SLC2A1 GLUT1 Epilepsy Phosphorylation N T234 P11166 6513 SLC2A1 GLUT1 Glioblastoma multiforme Phosphorylation N T234 P11166 6513 SLC2A1 GLUT1 Glut1 deficiency syndrome Phosphorylation N T234 P11166 6513 SLC2A1 GLUT1 Uterine corpus endometrial carcinoma Phosphorylation N T234 P11166 6513 SLC2A1 GLUT1 Colon adenocarcinoma Phosphorylation N T238 P11166 6513 SLC2A1 GLUT1 Epilepsy Phosphorylation N T238 P11166 6513 SLC2A1 GLUT1 Glioblastoma multiforme Phosphorylation N T238 P11166 6513 SLC2A1 GLUT1 Glut1 deficiency syndrome Phosphorylation N T238 P11166 6513 SLC2A1 GLUT1 Uterine corpus endometrial carcinoma Phosphorylation N T238 P11166 6513 SLC2A1 GLUT1 Epilepsy Ubiquitination N K245 P11166 6513 SLC2A1 GLUT1 Glut1 deficiency syndrome Ubiquitination N K245 P11166 6513 SLC2A1 GLUT1 Testicular germ cell tumor Ubiquitination N K245 P11166 6513 SLC2A1 GLUT1 Glut1 deficiency syndrome Phosphorylation N T258 P11166 6513 SLC2A1 GLUT1 Glut1 deficiency syndrome O-linked glycosylation N S465 P11166 6513 SLC2A1 GLUT1 Prostate adenocarcinoma O-linked glycosylation N S465 P11166 6513 SLC2A1 GLUT1 Glut1 deficiency syndrome Phosphorylation N S465 P11166 6513 SLC2A1 GLUT1 Prostate adenocarcinoma Phosphorylation N S465 P11166 6513 SLC2A1 GLUT1 Glut1 deficiency syndrome Phosphorylation C S473 P11166 6513 SLC2A1 GLUT1 Glut1 deficiency syndrome Phosphorylation N S473 P11166 6513 SLC2A1 GLUT1 Prostate adenocarcinoma Phosphorylation N S473 P11166 6513 SLC2A1 GLUT1 Skin cutaneous melanoma Phosphorylation N S473 P11166 6513 SLC2A1 GLUT1 Glut1 deficiency syndrome SUMOylation N K477 P11166 6513 SLC2A1 GLUT1 Skin cutaneous melanoma SUMOylation N K477 P11166 6513 SLC2A1 GLUT1 Glut1 deficiency syndrome Ubiquitination N K477 P11166 6513 SLC2A1 GLUT1 Skin cutaneous melanoma Ubiquitination N K477 P11166 6513 SLC2A1 GLUT1 Glut1 deficiency syndrome Phosphorylation N T478 P11166 6513 SLC2A1 GLUT1 Skin cutaneous melanoma Phosphorylation N T478 P11166 6513 SLC2A1 GLUT1 Glut1 deficiency syndrome Phosphorylation N S490 P21817 6261 RYR1 RYDR King-Denborough syndrome Ubiquitination N K29 P21817 6261 RYR1 RYDR RYR1-related disorders Phosphorylation C S157 P21817 6261 RYR1 RYDR Congenital myopathy Phosphorylation N S157 P21817 6261 RYR1 RYDR RYR1-related disorders Phosphorylation N S157 P21817 6261 RYR1 RYDR Congenital myopathy Acetylation N K161 P21817 6261 RYR1 RYDR Malignant hyperthermia Acetylation N K161 P21817 6261 RYR1 RYDR Malignant hyperthermia Phosphorylation N Y245 P21817 6261 RYR1 RYDR Prostate adenocarcinoma Phosphorylation N S781 P21817 6261 RYR1 RYDR RYR1-related disorders Phosphorylation N S781 P21817 6261 RYR1 RYDR Skin cutaneous melanoma Phosphorylation N S781 P21817 6261 RYR1 RYDR Breast cancer Phosphorylation N S1337 P21817 6261 RYR1 RYDR Malignant hyperthermia Ubiquitination N K1394 P21817 6261 RYR1 RYDR RYR1-related disorders Phosphorylation N Y1965 P21817 6261 RYR1 RYDR Head and neck squamous cell carcinoma Ubiquitination N K2069 P21817 6261 RYR1 RYDR Lung adenocarcinoma Ubiquitination N K2069 P21817 6261 RYR1 RYDR Malignant hyperthermia Ubiquitination N K2069 P21817 6261 RYR1 RYDR RYR1-related disorders Ubiquitination N K2069 P21817 6261 RYR1 RYDR Stomach adenocarcinoma Ubiquitination N K2069 P21817 6261 RYR1 RYDR Uveal melanoma Ubiquitination N K2069 P21817 6261 RYR1 RYDR Thyroid carcinoma Phosphorylation C S2085 P21817 6261 RYR1 RYDR Lung squamous cell carcinoma Phosphorylation N S2085 P21817 6261 RYR1 RYDR RYR1-related disorders Phosphorylation N S2085 P21817 6261 RYR1 RYDR Rectum adenocarcinoma Phosphorylation N S2085 P21817 6261 RYR1 RYDR Uterine corpus endometrial carcinoma Phosphorylation N S2085 P21817 6261 RYR1 RYDR Head and neck squamous cell carcinoma Methylation N R2118 P21817 6261 RYR1 RYDR Kidney renal clear cell carcinoma Methylation N R2118 P21817 6261 RYR1 RYDR Lung adenocarcinoma Methylation N R2118 P21817 6261 RYR1 RYDR Malignant hyperthermia Methylation N R2118 P21817 6261 RYR1 RYDR RYR1-related disorders Methylation N R2118 P21817 6261 RYR1 RYDR Malignant glioma Phosphorylation N S2345 P21817 6261 RYR1 RYDR Malignant hyperthermia Phosphorylation N S2345 P21817 6261 RYR1 RYDR Breast invasive carcinoma Phosphorylation N Y2426 P21817 6261 RYR1 RYDR Congenital myopathy Phosphorylation N Y2426 P21817 6261 RYR1 RYDR Malignant hyperthermia Phosphorylation N Y2426 P21817 6261 RYR1 RYDR Malignant hyperthermia Phosphorylation N S2459 P21817 6261 RYR1 RYDR Malignant hyperthermia Phosphorylation N S2594 P21817 6261 RYR1 RYDR Malignant hyperthermia Phosphorylation N T2596 P21817 6261 RYR1 RYDR Lung adenocarcinoma Phosphorylation N S2843 P21817 6261 RYR1 RYDR RYR1-related disorders Phosphorylation N S2843 P21817 6261 RYR1 RYDR Ovarian cancer Acetylation N K2953 P21817 6261 RYR1 RYDR Glioblastoma multiforme Phosphorylation N S3027 P21817 6261 RYR1 RYDR Hepatocellular carcinoma Phosphorylation N S3027 P21817 6261 RYR1 RYDR Lung adenocarcinoma Phosphorylation N S3027 P21817 6261 RYR1 RYDR Malignant hyperthermia Phosphorylation N S3027 P21817 6261 RYR1 RYDR RYR1-related disorders Phosphorylation N S3027 P21817 6261 RYR1 RYDR Stomach adenocarcinoma Phosphorylation N S3027 P21817 6261 RYR1 RYDR Glioblastoma multiforme Phosphorylation N S3032 P21817 6261 RYR1 RYDR Hepatocellular carcinoma Phosphorylation N S3032 P21817 6261 RYR1 RYDR Lung adenocarcinoma Phosphorylation N S3032 P21817 6261 RYR1 RYDR Malignant hyperthermia Phosphorylation N S3032 P21817 6261 RYR1 RYDR Melanoma Phosphorylation N S3032 P21817 6261 RYR1 RYDR RYR1-related disorders Phosphorylation N S3032 P21817 6261 RYR1 RYDR Skin cutaneous melanoma Phosphorylation N S3032 P21817 6261 RYR1 RYDR Stomach adenocarcinoma Phosphorylation N S3032 P21817 6261 RYR1 RYDR Skin cutaneous melanoma Phosphorylation N T3079 P21817 6261 RYR1 RYDR Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S3668 P21817 6261 RYR1 RYDR Hepatocellular carcinoma Phosphorylation N S3668 P21817 6261 RYR1 RYDR Prostate adenocarcinoma Phosphorylation N S3668 P21817 6261 RYR1 RYDR RYR1-related disorders Phosphorylation N S3668 P21817 6261 RYR1 RYDR Colon adenocarcinoma Phosphorylation N S3751 P21817 6261 RYR1 RYDR RYR1-related disorders Phosphorylation N S3751 P21817 6261 RYR1 RYDR Skin cutaneous melanoma Phosphorylation N S3751 P21817 6261 RYR1 RYDR Congenital myopathy Phosphorylation N T3771 P21817 6261 RYR1 RYDR Lung adenocarcinoma Phosphorylation N T3771 P21817 6261 RYR1 RYDR Malignant hyperthermia Phosphorylation N T3771 P21817 6261 RYR1 RYDR RYR1-related disorders Phosphorylation N T3771 P21817 6261 RYR1 RYDR Malignant hyperthermia Phosphorylation N T3918 P21817 6261 RYR1 RYDR Malignant hyperthermia Phosphorylation N Y3921 P21817 6261 RYR1 RYDR RYR1-related disorders Phosphorylation C S4212 P21817 6261 RYR1 RYDR Hepatocellular carcinoma Phosphorylation N S4212 P21817 6261 RYR1 RYDR RYR1-related disorders Phosphorylation N S4212 P21817 6261 RYR1 RYDR Colon adenocarcinoma Ubiquitination N K4551 P21817 6261 RYR1 RYDR RYR1-related disorders Ubiquitination N K4551 P21817 6261 RYR1 RYDR Stomach adenocarcinoma Ubiquitination N K4551 P21817 6261 RYR1 RYDR Congenital myopathy Phosphorylation N T4823 P21817 6261 RYR1 RYDR Malignant hyperthermia Phosphorylation N T4823 P21817 6261 RYR1 RYDR Congenital myopathy Phosphorylation N T4826 P21817 6261 RYR1 RYDR Malignant hyperthermia Phosphorylation N T4826 P21817 6261 RYR1 RYDR Congenital myopathy Phosphorylation N S4829 P21817 6261 RYR1 RYDR Malignant hyperthermia Phosphorylation N S4829 P21817 6261 RYR1 RYDR Malignant hyperthermia Phosphorylation N T4832 P21817 6261 RYR1 RYDR Congenital myopathy Phosphorylation N Y4864 P21817 6261 RYR1 RYDR Malignant hyperthermia Phosphorylation N Y4864 P21817 6261 RYR1 RYDR RYR1-related disorders Phosphorylation N Y4864 P21817 6261 RYR1 RYDR Uterine corpus endometrial carcinoma Phosphorylation N Y4864 P21817 6261 RYR1 RYDR Congenital myopathy Phosphorylation N S4867 P21817 6261 RYR1 RYDR Malignant hyperthermia Phosphorylation N S4867 P21817 6261 RYR1 RYDR RYR1-related disorders Phosphorylation N S4867 P21817 6261 RYR1 RYDR Uterine corpus endometrial carcinoma Phosphorylation N S4867 P11166 6513 SLC2A1 GLUT1 Glioma brain tissues N-linked glycosylation U 31494931 P11166 6513 SLC2A1 GLUT1 Bladder cancer tumor tissue Ubiquitination D 34906161 P11166 6513 SLC2A1 GLUT1 Glioblastoma tumor tissue S-palmitoylation P C207 34620861 P21817 6261 RYR1 RYDR Sepsis Serine phosphorylation U S2814 33460250 P11166 6513 SLC2A1 GLUT1 Bladder cancer BLCA tissue O-linked glycosylation U 38542435 P21817 6261 RYR1 RYDR Central core disease S-palmitoylation P C18 24509862